Operative Versus Non Operative Treatment for Unstable Ankle Fractures

September 6, 2016 updated by: David Sanders, Lawson Health Research Institute

A Prospective Randomized Multi-Centre Study to Compare Operative Versus Non Operative Functional Treatment in Patients With Unstable Isolated Fibula Fractures

The purpose of the study is to compare functional outcomes and recovery following surgical and non surgical treatment of potentially unstable , isolated fibula fractures. Secondary objectives are to compare the re-operation rate, time to union and complications between the two treatment groups.

The primary research questions:

  1. Does surgery provide a better functional outcome compared to non operative treatment of undisplaced, unstable fractures?
  2. Do patients with these fractures return to activities faster after operative or non operative treatment?
  3. Are complications more common with operative or non operative care?

Study Overview

Detailed Description

The most controversial ankle fracture is the Weber B fracture in which the fibular (or lateral malleolar) fracture begins at the level of the ankle mortise and extends proximal and lateral. This fracture can exist as isolated fractures of the lateral malleolus, or bimalleolar injuries in which both lateral and medial malleoli are fractured. When both malleoli are fractured, the ankle has lost all of its bony support and is unstable. In contrast, if only the lateral malleolus is injured, the Weber B injury may be either stable or unstable. When the ankle is subluxed or dislocated in these injuries, the ankle is clearly unstable. However, when the ankle is not initially subluxed, the assessment of stability is more difficult. Stability in isolated lateral malleolar fractures depends upon the status of the medial, or deltoid, ligaments. Further complicating matters, the deltoid ligament may be intact, partially torn, or completely torn such that there is a spectrum of stability for these injuries.Previous studies relied upon an assessment of tenderness over the ligament to determine instability, but this may not differentiate between partial and complete tears.

In North America, most surgeons would agree that markedly unstable definitely unstable ankle fractures are best treated surgically.Therefore, Weber B fractures which involve fractures of both the medial and lateral malleolus are best treated by surgical stabilization. Furthermore, Weber B fractures involving only the lateral malleolus, but which present with lateral subluxation of the talus, are definitely unstable and require fixation.

In contrast, controversy exists between surgeons regarding the optimal means of treating an undisplaced but potentially unstable fibula fracture. Many surgeons recommend routine operative fixation, while others recommend routine non-operative treatment.A clear rationale exists for both types of treatment.

The most important factor in treatment includes maintaining the reduction of the talus within the ankle mortise. Even 1 mm of displacement or lateral shift of the talus will affect ankle joint loading and lead to dysfunction and potentially arthritis. Other issues include the potential benefits of earlier mobilization and rehabilitation.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • LOndon, Ontario, Canada, N6A 4G5
        • London Health Sciences Centre- Victoria Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Skeletally mature male or female < 65 years of age
  2. Unstable ankle on stress exam: medial clear space ³ 5 mm: no Mortise shift on static radiographs
  3. Unilateral Weber B fibular fractures
  4. Closed fracture
  5. Provision of informed consent -

Exclusion Criteria:

  1. Fractures not amenable to surgical treatment
  2. Pathologic fracture
  3. Associated injuries to the foot, ankle, tibia, or knee
  4. Associated medial malleolus fracture
  5. Surgical delay of >2 weeks from time of injury
  6. Previous fracture or retained hardware in the affected limb
  7. Associated neurovascular injury or deficit in the affected limb
  8. Systemic diseases including diabetes, multiple sclerosis, Parkinson's disease, and other disorders which might affect peripheral sensorimotor function -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
Non operative treatment of Weber B ankle fracture. Use of cast, with no surgical intervention
non operative treatment -casting for 6 weeks
Active Comparator: 2
Operative treatment of Weber B ankle fracture. Open reduction and internal fixation to repair a broken bones.
operative treatment of ankle fractures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Primary outcome: comparison of physical functioning score on SF36
Time Frame: enrolment, 6 weeks, 3,6 12 months
enrolment, 6 weeks, 3,6 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary objectives are to compare the re-operation rate between operative and non-operative treatment and to compare the time to union, rates of nonunion and complications such as infection between the two groups.
Time Frame: enrolment, 6 weeks, 3,6,12 months
Number of participants with complications or adverse events that ae related to treatment
enrolment, 6 weeks, 3,6,12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: DR. David Sanders, M.D., FRCSC, Western University, Canada

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2003

Primary Completion (Actual)

August 1, 2010

Study Completion (Actual)

August 1, 2010

Study Registration Dates

First Submitted

June 13, 2006

First Submitted That Met QC Criteria

June 13, 2006

First Posted (Estimate)

June 14, 2006

Study Record Updates

Last Update Posted (Estimate)

September 7, 2016

Last Update Submitted That Met QC Criteria

September 6, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • R-03-113
  • HSREB09641 (Other Identifier: Western University Research Ethics)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Injuries

Clinical Trials on non operative treatment

Subscribe